• The tense of the verbs is awkward. This is throughout the manuscript: "will do" rather than "was" done • Formatting odd (no results) Introduction: states that bone is the most common site of metastases from lung cancer • The references do not support this statement • Coleman sites frequency of bone metastases but does not compare it to other sites • 30-40% of patients with advanced lung cancer develop bone metastases, but 40% develop brain metastases • Citing rodent model reference for clinical data does not support this statement Methods:
GENERAL COMMENTS
The abstract & the manuscript do not have ANY results presented.
Once the manuscript is complete with a results section a statistical review is recommended.
In general, the manuscript was an awkward read, contained incorrect information, lacked information in some spots while being redundant in others.
Abstract:
• The tense of the verbs is awkward. This is throughout the manuscript: "will do" rather than "was" done • Formatting odd (no results)
Introduction: states that bone is the most common site of metastases from lung cancer • The references do not support this statement • Coleman sites frequency of bone metastases but does not compare it to other sites • 30-40% of patients with advanced lung cancer develop bone metastases, but 40% develop brain metastases • Citing rodent model reference for clinical data does not support this statement Methods:
• The end date of the search was not specified • There is excessive text on page 9 in the primary outcome Primary outcome. The discussion of lymphatic or hematologic spread does not appear appropriately placed. The section does not define how the systematic review will define bone metastases in the papers to be reviewed.
• Page 14 states that "Because the incidence of bone metastases is relatively low…." Note that this is in contrast to the Introduction. 
It is unclear to me whether or not this article actually meets the publication criteria of the BMJ Open journal. It is describing a plan for performing a meta-analysis, but they haven't actually done it yet. It is only the proposal here. As such there is no data presented or analyzed or anything although they do seem to have proposed appropriate methods for the most part. I am not sure they are including appropriate methods for determining the quality of the manuscripts they propose to include, ie using QUADAS to assess manuscript suitability for inclusion I am not sure if only the planned meta-analysis is suitable for publication without the results of said analysis. The authors should also consider using tools such as QUADAS to test the suitability and quality of the papers they will include in their analysis.
VERSION 1 -AUTHOR RESPONSE
Reviewer Name Catherine Van Poznak 1.Please state any competing interests or state 'None declared': no associated conflicts of interest to report.
Response: The competing interests are now explicitly stated in the last part of this manuscript.
2. (2.1) In general, the manuscript was an awkward read, (2.2) contained incorrect information, (2.3) lacked information in some spots while being redundant in others.
Response: 2.1. I am so sorry to fail to find out a native English speaker, because our university has some restrictions on the network and it is still a restricted area. So I have had the manuscript read by several professors and English teacher. I sincerely hope you can understand us and help us.
Response: 2.2. Following the reviewer's advice, I have corrected incorrect information. This was accomplished primarily by: (1) correcting the states that bone is the most common site of metastases from lung cancer; (2) eliminating incorrect references do not support this statement; (3) correcting the states that "Because the incidence of bone metastases is relatively low…"
Response: 2.3. I have tried to provide explicitly information in some spots, and eliminated redundant statements. This was accomplished primarily by: (1) Competing interests are now stated in the last sentence of the manuscript; (2) The end date of the search is now stated in the second paragraph of Data sources of Search strategy for the review; (3) The frequency of bone metastases and the number of patients who may experience SREs are now addressed in the second paragraph of Introduction; (4) I have eliminated the text on page 9 in the primary outcome. The discussion of lymphatic or hematologic spread has been cut, and replaced by "patients with lung cancer in all studies had one or more radiographically confirmed bone metastasis"; (5) I have pared down the text of Discussion.
3.Abstract: The tense of the verbs is awkward. This is throughout the manuscript: "will do" rather than "was" done.
Response: This was accomplished primarily by: (1) correcting "was/have done" to "will do"; (2) having the manuscript read by several professors and English teacher as I failed to have the manuscript edited by a native English speaker.
4.Formatting odd (no results)
Response: The format of abstract has been modified. I have reorganized subheadings to follow preferred structure for abstracts for protocols in instructions for authors.
5.Introduction: state that bone is most common site of metastases from lung cancer • The references do not support this statement
• Coleman sites frequency of bone metastases but does not compare it to other sites.
• 30-40% of patients with advanced lung cancer develop bone metastases, but 40% develop brain metastases.
• Citing rodent model reference for clinical data does not support this statement.
Response: Following the reviewer's advice, this statement was corrected in the first sentence of Introduction. This was accomplished by:
• correcting the states that bone is the most common site of metastases from lung cancer;
• eliminating incorrect references do not support this statement;
• Roodman 2004 have been added for support this statement.
6.Methods: The end date of the search was not specified.
Response: The end date of the search is now stated as "June 2014" in the second paragraph of Data sources of Search strategy for the review.
7.Methods: There is excessive text on page 9 in the primary outcome of Primary Outcome. The discussion of lymphatic or hematologic spread does not appear appropriately placed. The section does not define how the systematic review will define bone metastases in the papers to be reviewed.
Response: I have deleted the text on page 9 in the primary outcome. The discussion of lymphatic or hematologic spread has been cut, and replaced by "patients with lung cancer in all studies had one or more radiographically confirmed bone metastasis".
8.Methods: Page 14 states that "Because the incidence of bone metastases is relatively low…". Note that this is in contrast to the Introduction.
Response: I have corrected the states that "Because the incidence of bone metastases is relatively low…", and now explicitly state "Because the incidence of bone metastasis in patients with lung cancer is about 30-40%, we consider that estimates of ORs wouldn't approximate the estimates of the relative risks (RRs, HRs)." 9.Methods: It is important that the authors address the frequency of bone metastases and then number of patients who may experience SREs in order to make a cogent argument that the work done within this paper may ultimately have clinical utility.
Response: I have addressed the frequency and the number of patients who may experience SREs in the second paragraph in Introduction.
10.Discussion: This section repeats prior sections and does not add new information.
Response: I have pared down the text of Discussion.
11.Given the high frequency of lung cancer and the short life expectancy of patients with metastatic lung cancer, it would be of interest to know how to optimally utilize the osteoclast inhibitors for palliation & for cost effectiveness. The submitted document is not poised to address this need, but it is a small step closer.
Response: Thank you so much for your encouragements! Our team will take your suggestions to heart and follow your advice in our next research. I sincerely hope to keep in touch with you for your meticulous scholarship. Do you mind I send you email for further communication? Thank you very much! Our signal will be "BM of LC", OK?
Reviewer Name Christina Addison 1.Please state any competing interests or state 'None declared': None declared.
2.I am not sure if only the planned meta-analysis is suitable for publication without the results of said analysis. The authors should also consider using tools such as QUADAS to test the suitability and quality of the papers the will include in their analysis.
Response: Thank you for your advice about data analysis! For identifying evidence-based risk factors for specific disease, several papers have been published and can be retrieved from the network. Such as Holodinsky published their paper in 2013: "Risk factors for intra-abdominal hypertension and abdominal compartment syndrome among adult intensive care unit patients: a systematic review and meta-analysis"; Acedillo published their research results in 2013: "The Risk of Perioperative Bleeding in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis", and so on.
And, we all know the QUADAS is a tool for evaluating diagnostic accuracy studies. Besides, scales with multiple items and complex scoring systems take more time to complete than simple approaches. They may carry a greater risk of confusing the quality of reporting with the validity of the study. For these reasons, we consider to use simple approaches for assessing suitability and quality that can be fully reported. Your advice is so impressive and important that we have read more researches and papers about QUADAS and Observational studies these days. Thank you for your suggestion again! We will be more careful and take your question to heart in the next work of this study!
